Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Operating Income (2020 - 2025)

SOPHiA GENETICS's Operating Income history spans 6 years, with the latest figure at -$18.5 million for Q4 2025.

  • On a quarterly basis, Operating Income fell 6.15% to -$18.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$70.9 million, a 6.52% decrease, with the full-year FY2025 number at -$70.9 million, down 6.52% from a year prior.
  • Operating Income hit -$18.5 million in Q4 2025 for SOPHiA GENETICS, down from -$17.9 million in the prior quarter.
  • Over the last five years, Operating Income for SOPH hit a ceiling of -$14.1 million in Q1 2021 and a floor of -$25.0 million in Q1 2022.
  • Historically, Operating Income has averaged -$18.6 million across 5 years, with a median of -$18.5 million in 2025.
  • The widest YoY moves for Operating Income: up 99.78% in 2021, down 86.13% in 2021.
  • Tracing SOPH's Operating Income over 5 years: stood at -$21.0 million in 2021, then grew by 28.21% to -$15.1 million in 2022, then decreased by 25.61% to -$18.9 million in 2023, then rose by 7.93% to -$17.4 million in 2024, then fell by 6.15% to -$18.5 million in 2025.
  • Business Quant data shows Operating Income for SOPH at -$18.5 million in Q4 2025, -$17.9 million in Q3 2025, and -$18.5 million in Q2 2025.